ONCOCROSS Co., Ltd.
AI, drug discovery development, biotechnology, indication expansion, rare disease, intractable disease, oncology, CUP
18 employees · est. 2015 · Seoul, Korea South
-Sci-&-Tech-Co.-logo.jpg "Zensun (Shanghai) Sci & Tech Co."){kind=logo}
Zensun (Shanghai) Sci & Tech Co.
Healing through innovation, delivering life-saving therapies for the unmet needs of tomorrow
est. 2000
Zensun (Shanghai) Sci & Tech Co. is the older company (2015 vs 2000).
Side-by-Side Comparison
| Metric | ONCOCROSS Co., Ltd. | Zensun (Shanghai) Sci & Tech Co. |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2000 older |
| Headquarters | ||
| Headquarters | Seoul, Korea South | Not tracked yet |
| Employees | ||
| Employees | 18 | Not tracked yet |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biopharma, Biotechnology |
| Funding Stage | ||
| Funding Stage | Corporate Round | Series Unknown |
| Total Funding | ||
| Total Funding | $18.00B | $507.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 1 |
| Services | ||
| Services | AI platforms for drug discovery, Cancer treatment predictive modeling, Customized medication development, In vitro and in vivo drug analysis, Collaborative AI research initiatives | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotech firms, Healthcare researchers, Oncologists, Medical data analysts | Not tracked yet |
| Taxonomy | ||
| Taxonomy | AI In Drug Discovery, Transcriptomic Database, Rare Disease Treatments, Intractable Diseases, Oncology, Pharmaceutical Partnerships, Indication Expansion, NCE Indications, Reviving Failed Compounds, Drug Combination Screening, Cancer Biomarkers, CUP Diagnostics, Clinical Risk Reduction, Cost-Effective Drug Development | Biopharmaceutical, Innovation, Therapeutic Products, Cardiovascular Disease, Anti-cancer Drugs, Energy Metabolism Disorders, Life-saving Therapies, Novel Disease-specific Targets, Patented Discoveries, Advanced Technologies, Unmet Medical Needs, Heart Failure, Cancer Treatments |
| Website | ||
| Website | oncocross.com | zensunus.com |
About ONCOCROSS Co., Ltd.
ONCOCROSS Co., Ltd., founded in 2015, is a South Korean biotechnology and pharmaceutical innovator leveraging AI to revolutionize drug discovery and development. Positioned at the intersection of biotechnology and pharmaceutical industries, ONCOCROSS focuses on tackling challenging problems like rar...
About Zensun (Shanghai) Sci & Tech Co.
Zensun (Shanghai) Sci & Tech Co. is a biopharmaceutical and biotechnology company founded in 2000, dedicated to developing innovative bio-therapeutic products to address serious and life-threatening unmet medical needs. The company's slogan "Healing through innovation, delivering life-saving therapi...
We will tell you when either one moves
BounceWatch watches ONCOCROSS Co., Ltd. and Zensun (Shanghai) Sci & Tech Co. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ONCOCROSS Co., Ltd. and Zensun (Shanghai) Sci... — by email.
Frequently Asked Questions
Compare ONCOCROSS Co., Ltd. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ONCOCROSS Co., Ltd. on 15 Jun 2026, and Zensun (Shanghai) Sci & Tech Co. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
